As TrialSite reported on March 18, Moderna is launching COVID-19 vaccine trials for those aged six months to 12 years. Despite the fact that folks…
Moderna recently announced that the first participants in the Phase 2/3 KidCOVE study were dosed in what is the first vaccine trial involving children aged…
Trial site organizations: if you are too busy, big sponsors may pass up on you. Or could this also imply they think you’re too small? That’s…
Clinical trials have opened up to test the mRNA-based Moderna COVID-19 vaccine on children from 6 months to 12 years old, making Moderna the first…
Charleston, South Carolina-based Coastal Pediatric Research was recently selected by Moderna to participate in their pediatric COVID-19 vaccine trials, the only such site in the…
As TrialSite has monitored allergic vaccine reactions associated with mRNA-based COVID-19 vaccines under U.S. Food and Drug Administration (FDA) emergency use authorization (Pfizer/BioNTech and Moderna),…
Moderna Inc. (Nasdaq: MRNA), the biotechnology company with one of the authorized vaccines for COVID-19, completed the manufacturing of clinical trial material for its variant-specific…
Moderna announced the results from in vitro neutralization studies of sera from individuals vaccinated with Moderna COVID-19 Vaccine showing activity against emerging strains of SARS-CoV-2.…
Ongoing inoculations throughout pandemic-weary California unfortunately hasn’t unfolded in a smooth and seamless manner and now state health officials placed at least one health clinic…
Research Centers of America (“RCA”), a CenExel Center of Excellence, joined nearly 100 other clinical research facilities across the United States to test the safety…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
